Diseases, Conditions, Syndromes

New bronchoscopic option used for severe emphysema

(HealthDay)—Temple University Hospital has become the first center in the U.S. to perform bronchoscopic lung volume reduction using implantation of the Zephyr Endobronchial Valve (Zephyr EBV) to treat hyperinflation associated ...

Cardiology

Research supports pulmonary benefits for ACEIs, ARBs

(HealthDay)—Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) might play an important role in the prevention and treatment of emphysema, according to a study published in the May ...

Cardiology

ACE inhibitors, ARBs may slow percent emphysema progression

(HealthDay)—Use of angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) is associated with slowed progression of percent emphysema on chest computed tomography (CT), according to a study ...

Diseases, Conditions, Syndromes

Emphysema treatment could be optimized using network modelling

A unique engineering perspective of emphysema progression in the lung suggests how mechanisms operating at the micromechanical scale could help to predict patient survival and quality of life following treatment - according ...

Diseases, Conditions, Syndromes

Interlobar collateral ventilation impacts EB valve outcomes

(HealthDay)—A more careful selection of patients could help improve the success rate of bronchoscopic lung-volume reduction with the use of one-way endobronchial valves in patients with emphysema, according to a study published ...

Diseases, Conditions, Syndromes

Imaging could improve treatment of people with COPD

Magnetic resonance imaging (MRI) and computed tomography (CT) provide important information on the symptoms and exercise capabilities of people with mild-to-moderate chronic obstructive pulmonary disease (COPD), according ...

page 3 from 8